ACKNOWLEDGMENT
We wish to thank the patients who participated in FOxTROT and all staff who have supported the trial. The patient representative for the trial was Alf Oliver. He contributed for the entire duration of the trial and was an active member of the trial management group.See See accompanying editorial on page 